Generic placeholder image

Infectious Disorders - Drug Targets

Author(s): Medha Dwivedi, Aiswarya Pawar, Mahima Kori, Hitendra Yadav and Manish Dwivedi*

DOI: 10.2174/0118715265305007240718081727

DownloadDownload PDF Flyer Cite As
A Review on the Epidemiology and Clinical Management of Neglected Tropical Diseases

Article ID: e18715265305007 Pages: 15

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Infectious disorders known as Neglected Tropical Diseases (NTDs) initially affect the world's underprivileged citizens. They have been disregarded for many years, first as a result of a general indifference to such a developing world and, more recently, as an outcome of the intense attention on AIDS, TB, and malaria. Tropical diseases mostly affect the region where health and hygiene are sacrificed, and most of the population lacks access to sufficient food and living resources. WHO has drafted and released the directions for regulation, prevention, and successful eradication of NTDs as per the revised roadmap of 2021-2030. This shifts from vertical disease programs to integrated cross-cutting methods. In the current work, we have provided comprehensive information on various aspects of neglected tropical diseases, including the clinical management of NTDs. This encompasses the causative agent of the diseases, their symptoms, pathogenesis, diagnosis, treatment, prognosis, and epidemiological perspective of major NTDs. This review will shed light on several perspectives of NTDs having influential roles in proposing strategies to control and treat them around the world.

Keywords: Neglected tropical diseases, infection, epidemiological, pathogenesis, therapeutics, therapy.

[1]
Hotez PJ, Aksoy S, Brindley PJ, Kamhawi S. What constitutes a neglected tropical disease? PLoS Negl Trop Dis 2020; 14(1): e0008001.
[http://dx.doi.org/10.1371/journal.pntd.0008001] [PMID: 31999732]
[2]
Hotez PJ. NTDs V.2.0: “blue marble health”--neglected tropical disease control and elimination in a shifting health policy landscape. PLoS Negl Trop Dis 2013; 7(11): e2570.
[http://dx.doi.org/10.1371/journal.pntd.0002570] [PMID: 24278496]
[3]
Hotez PJ, Kamath A. Neglected tropical diseases in sub-saharan africa: Review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009; 3(8): e412.
[http://dx.doi.org/10.1371/journal.pntd.0000412]
[4]
Hotez PJ. "A plan to defeat neglected tropical diseases". Sci Am 2010; 302(1): 90-4.
[http://dx.doi.org/10.1038/scientificamerican0110-90]
[5]
"World Health Organization". World Health Organization". 2017.
[6]
Malecela MN, Ducker C. A road map for neglected tropical diseases 2021–2030. Trans R Soc Trop Med Hyg 2021; 115(2): 121-3.
[http://dx.doi.org/10.1093/trstmh/trab002] [PMID: 33508095]
[7]
GBD 2013 mortality causes of death collaborators (2015). “Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013". Lancet 2015; 385(9963): 117-71.
[http://dx.doi.org/10.1016/S0140-6736(14)61682-2]
[8]
Manry J. Human genetics of Buruli ulcer. Hum Genet 2020; 139(6-7): 847-53.
[http://dx.doi.org/10.1007/s00439-020-02163-1] [PMID: 32266523]
[9]
Monteiro FA, Weirauch C, Felix M, Lazoski C, Abad-Franch F. Evolution, systematics, and biogeography of the triatominae, vectors of chagas disease. Adv Parasitol 2018; 99: 265-344.
[http://dx.doi.org/10.1016/bs.apar.2017.12.002] [PMID: 29530308]
[10]
Garrett KB, Box EK, Cleveland CA, Majewska AA, Yabsley MJ. Dogs and the classic route of guinea worm transmission: An evaluation of copepod ingestion. Sci Rep 2020; 10(1): 1430.
[http://dx.doi.org/10.1038/s41598-020-58191-4]
[11]
Del Brutto OH, García HH. Taenia solium Cysticercosis — The lessons of history. J Neurol Sci 2015; 359(1-2): 392-5.
[http://dx.doi.org/10.1016/j.jns.2015.08.011] [PMID: 26320098]
[12]
Siles-Lucas M, Casulli A, Cirilli R, Carmena D. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets. PLoS Negl Trop Dis 2018; 12(4): e0006422.
[http://dx.doi.org/10.1371/journal.pntd.0006422]
[13]
Aksoy DY, Kerimoglu U, Oto A, et al. Infection with fasciola hepatica. Clin Microbiol Infect 2005; 11(11): 859-61.
[http://dx.doi.org/10.1111/j.1469-0691.2005.01254.x] [PMID: 16216098]
[14]
Schmidt RS, Macêdo JP, Steinmann ME, et al. Transporters of Trypanosoma brucei —phylogeny, physiology, pharmacology. FEBS J 2018; 285(6): 1012-23.
[http://dx.doi.org/10.1111/febs.14302] [PMID: 29063677]
[15]
Okwor I, Uzonna J. Social and economic burden of human leishmaniasis. Am J Trop Med Hyg 2016; 94(3): 489-93.
[http://dx.doi.org/10.4269/ajtmh.15-0408] [PMID: 26787156]
[16]
Sugawara-Mikami M, Tanigawa K, Kawashima A, et al. Pathogenicity and virulence of Mycobacterium leprae. Virulence 2022; 13(1): 1985-2011.
[http://dx.doi.org/10.1080/21505594.2022.2141987] [PMID: 36326715]
[17]
Small ST, Tisch DJ, Zimmerman PA. Molecular epidemiology, phylogeny and evolution of the filarial nematode Wuchereria bancrofti. Infect Genet Evol 2014; 28: 33-43.
[http://dx.doi.org/10.1016/j.meegid.2014.08.018] [PMID: 25176600]
[18]
Fahal AH. Mycetoma: A thorn in the flesh. Trans R Soc Trop Med Hyg 2004; 98(1): 3-11.
[http://dx.doi.org/10.1016/S0035-9203(03)00009-9] [PMID: 14702833]
[19]
Elgart ML. Onchocerciasis and dracunculosis. Dermatol Clin 1989; 7(2): 323-30.
[http://dx.doi.org/10.1016/S0733-8635(18)30603-X] [PMID: 2527659]
[20]
Norman FF, Comeche B, Chamorro S, López-Vélez R. Overcoming challenges in the diagnosis and treatment of parasitic infectious diseases in migrants. Expert Rev Anti Infect Ther 2020; 18(2): 127-43.
[http://dx.doi.org/10.1080/14787210.2020.1713099] [PMID: 31914335]
[21]
Anderson R, Truscott J, Hollingsworth TD. The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths. Philos Trans R Soc Lond B Biol Sci 2014; 369(1645): 20130435.
[http://dx.doi.org/10.1098/rstb.2013.0435]
[22]
Lietman TM, Pinsent A, Liu F, Deiner M, Hollingsworth TD, Porco TC. Models of trachoma transmission and their policy implications: From control to elimination. Clin Infect Dis 2018; 66 (Suppl. 4): S275-80.
[http://dx.doi.org/10.1093/cid/ciy004] [PMID: 29860288]
[23]
Lee TH, Lee LK, Lye DC, Leo YS. Current management of severe dengue infection. Expert Rev Anti Infect Ther 2017; 15(1): 67-78.
[http://dx.doi.org/10.1080/14787210.2017.1248405] [PMID: 27786589]
[24]
Hurt JB, Maday KR. Management and treatment of animal bites. JAAPA 2018; 31(4): 27-31.
[http://dx.doi.org/10.1097/01.JAA.0000531049.59137.cd] [PMID: 30973531]
[25]
"Trypanosomiasis, human African (sleeping sickness)" www.who.int
[26]
Simarro PP, Cecchi G, Franco JR, et al. Estimating and mapping the population at risk of sleeping sickness. PLoS Negl Trop Dis 2012; 6(10): e1859.
[http://dx.doi.org/10.1371/journal.pntd.0001859] [PMID: 23145192]
[27]
Kagbadouno MS, Camara M, Rouamba J, et al. Epidemiology of sleeping sickness in boffa (Guinea): Where are the trypanosomes? PLoS Negl Trop Dis 2012; 6(12): e1949.
[http://dx.doi.org/10.1371/journal.pntd.0001949] [PMID: 23272259]
[28]
Mugenyi A, Muhanguzi D, Hendrickx G, et al. Spatial analysis of G.f.fuscipes abundance in uganda using poisson and zero-inflated poisson regression models. PLoS Negl Trop Dis 2021; 15(12): e0009820.
[http://dx.doi.org/10.1371/journal.pntd.0009820]
[29]
Vos T, Allen C, Arora M, et al. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388(10053): 1545-602.
[http://dx.doi.org/10.1016/S0140-6736(16)31678-6] [PMID: 27733282]
[30]
Trypanosomiasis, human African (sleeping sickness). World Health Organization. 2014. Available from: https://www.who.int/news-room/fact-sheets/detail/trypanosomiasis-human-african-(sleeping-sickness)
[31]
Simarro P, Franco J, Diarra A, Jannin J. Epidemiology of human African trypanosomiasis. Clin Epidemiol 2014; 6: 257-75.
[http://dx.doi.org/10.2147/CLEP.S39728] [PMID: 25125985]
[32]
Olowe SA. A case of congenital trypanosomiasis in Lagos. Trans R Soc Trop Med Hyg 1975; 69(1): 57-9.
[http://dx.doi.org/10.1016/0035-9203(75)90011-5] [PMID: 1170654]
[33]
Rocha G, Martins A, Gama G, Brandão F, Atouguia J. Possible cases of sexual and congenital transmission of sleeping sickness. Lancet 2004; 363(9404): 247.
[http://dx.doi.org/10.1016/S0140-6736(03)15345-7] [PMID: 14738812]
[34]
Cherenet T, Sani RA, Panandam JM, Nadzr S, Speybroeck N, Van den Bossche P. Seasonal prevalence of bovine trypanosomosis in a tsetse-infested zone and a tsetse-free zone of the Amhara Region, north-west Ethiopia. Onderstepoort J Vet Res 2004; 71(4): 307-12.
[http://dx.doi.org/10.4102/ojvr.v71i4.250] [PMID: 15732457]
[35]
Cornford EM, Bocash WD, Braun LD, Crane PD, Oldendorf WH, MacInnis AJ. Rapid distribution of tryptophol (3-indole ethanol) to the brain and other tissues. J Clin Invest 1979; 63(6): 1241-8.
[http://dx.doi.org/10.1172/JCI109419] [PMID: 447842]
[36]
Lundkvist GB, Kristensson K, Bentivoglio M. Why trypanosomes cause sleeping sickness. Physiology (Bethesda) 2004; 19(4): 198-206.
[http://dx.doi.org/10.1152/physiol.00006.2004] [PMID: 15304634]
[37]
"CDC - African Trypanosomiasis - Disease" 2020. Available from: www.cdc.gov
[38]
Truc P, Lejon V, Magnus E, et al. Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in west and central africa. Bull World Health Organ 2002; 80(11): 882-6.
[PMID: 12481210]
[39]
"Fexinidazole, the first all-oral treatment for sleeping sickness, approved in democratic republic of congo – DNDi" Available from: www.dndi.org
[40]
Lutje V, Seixas J, Kennedy A. Chemotherapy for second-stage human african trypanosomiasis. Cochrane Libr 2013; 2013(6): CD006201.
[http://dx.doi.org/10.1002/14651858.CD006201.pub3] [PMID: 23807762]
[41]
World health organization. In: World Health Report 2000. Health Systems Improving Performance. Geneva 2000.
[42]
Franco JR, Cecchi G, Priotto G, et al. Monitoring the elimination of human African trypanosomiasis: Update to 2014. PLoS Negl Trop Dis 2017; 11(5): e0005585.
[http://dx.doi.org/10.1371/journal.pntd.0005585] [PMID: 28531222]
[43]
World health organizationTrypanosomiasis, human African (sleeping sickness). Geneva: World Health Organization 2023.
[44]
World Health Organization. Report of the third WHO stakeholders meeting on gambiense human African trypanosomiasis elimination 2020; 18-20.
[45]
Roy M, Rawat A, Kaushik S, Jyoti A, Srivastava VK. 2022; Endogenous cysteine protease inhibitors in upmost pathogenic parasitic protozoa. Microbiol Res 2022; 261: 127061.
[http://dx.doi.org/10.1016/j.micres.2022.127061]
[46]
Rawat A, Roy M, Jyoti A, Kaushik S, Verma K, Srivastava VK. Cysteine proteases: Battling pathogenic parasitic protozoans with omnipresent enzymes. Microbiol Res 2021; 249: 126784.
[http://dx.doi.org/10.1016/j.micres.2021.126784] [PMID: 33989978]
[47]
Leishmaniasis Fact sheet N°375 In: World Health Organization. 2014.
[48]
Barrett MP, Croft SL. Management of trypanosomiasis and leishmaniasis. Br Med Bull 2012; 104(1): 175-96.
[http://dx.doi.org/10.1093/bmb/lds031] [PMID: 23137768]
[49]
Myler PJ, Fasel N. Caister Academic Press. 2008. Leishmania: After. The Genome.
[50]
Dacie JV, Bain BJ, Bates I. Dacie and Lewis practical hematology. Philadelphia: Churchill Livingstone/Elsevier 2006.
[51]
Custodio E, López-Alcalde J, Herrero M, et al. Nutritional supplements for patients being treated for active visceral leishmaniasis. Cochrane Libr 2018; 2018(3): CD012261.
[http://dx.doi.org/10.1002/14651858.CD012261.pub2] [PMID: 29578237]
[52]
Alexander B, Maroli M. Control of phlebotomine sandflies. Med Vet Entomol 2003; 17(1): 1-18.
[http://dx.doi.org/10.1046/j.1365-2915.2003.00420.x] [PMID: 12680919]
[53]
"Leishmaniasis: Situation and trends" In: WHO Global Health Observatory. 2018.
[54]
"Leishmaniasis: Magnitude of the problem". In: World Health Organization. 2013.
[55]
"Hope for tropical disease vaccine". In: BBC News. 2006.
[56]
"Informes informe de fronteras febrero 2005". In: Servicio Jesuita a Refugiados. 2005.
[57]
Kennedy K. 2010.VCS advocacy in the news: VA may designate 9 infectious diseases as related to gulf war In: Veterans for Common Sense. 2011.
[58]
"Business: Company's mesh will help troops beat 'Baghdad boils'". In: . 2005.
[59]
Bhatia S, Goli D. Leishmaniasis: Biology, Control and New Approaches for Its Treatment. CRC Press 2016.
[http://dx.doi.org/10.1201/9781315366111]
[60]
van Thiel PP, van der Meide WF, van der Sluis A, et al. Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment. Am J Trop Med Hyg 2010; 83(6): 1295-300.
[http://dx.doi.org/10.4269/ajtmh.2010.10-0143] [PMID: 21118937]
[61]
Aguado M, Espinosa P, Romero-Maté A, Tardío JC, Córdoba S, Borbujo J. Outbreak of cutaneous leishmaniasis in Fuenlabrada, Madrid. Actas Dermo-Sifiliográficas (English Edition) 2013; 104(4): 334-42.
[http://dx.doi.org/10.1016/j.adengl.2013.03.005] [PMID: 23567452]
[62]
""Chagas disease (American trypanosomiasis)". In: World Health Organization. 2019.
[63]
Guarner J. Chagas disease as example of a reemerging parasite. Semin Diagn Pathol 2019; 36(3): 164-9.
[http://dx.doi.org/10.1053/j.semdp.2019.04.008] [PMID: 31006555]
[64]
Bern C. Chagas’ disease. N Engl J Med 2015; 373(5): 456-66.
[http://dx.doi.org/10.1056/NEJMra1410150] [PMID: 26222561]
[65]
""DPDx – Trypanosomiasis, American. Fact Sheet". In: Centers for Disease Control (CDC) 2019.
[66]
Pérez-Molina JA, Molina I. Chagas disease. Lancet 2018; 391(10115): 82-94.
[http://dx.doi.org/10.1016/S0140-6736(17)31612-4] [PMID: 28673423]
[67]
Robertson LJ, Devleesschauwer B, Alarcón de Noya B, Noya González O, Torgerson PR. Trypanosoma cruzi: Time for international recognition as a foodborne parasite. PLoS Negl Trop Dis 2016; 10(6): e0004656.
[http://dx.doi.org/10.1371/journal.pntd.0004656] [PMID: 27253136]
[68]
Despommier DD, Griffin DO, Gwadz RW, Hotez PJ, Knirsch CA. American Trypanosomiasis. In: Parasitic Diseases. (7th ed.). New York: Parasites Without Borders 2019; pp. 71-84.
[69]
Bain BJ. Blood Cells: A Practical Guide. John Wiley & Sons 2015; pp. 165-7.
[70]
Bern C, Messenger LA, Whitman JD, Maguire JH. Chagas disease in the united states: A public health approach. Clin Microbiol Rev 2019; 33(1)
[http://dx.doi.org/10.1128/CMR.00023-19]
[71]
Schijman AG. Molecular diagnosis of Trypanosoma cruzi. Clin Microbiol Rev 2018; 33(1)
[http://dx.doi.org/10.1016/j.actatropica.2018.02.019]
[72]
Luquetti AO, Schijman AG. Switzerland: Springer Nature Diagnosis of Chagas disease In: Chagas Disease: A Clinical Approach . 2019; pp. 141-58.
[http://dx.doi.org/10.1007/978-3-030-00054-7_7]
[73]
Angheben A, Buonfrate D, Cruciani M, et al. Rapid immunochromatographic tests for the diagnosis of chronic Chagas disease in at-risk populations: A systematic review and meta-analysis. PLoS Negl Trop Dis 2019; 13(5): e0007271.
[http://dx.doi.org/10.1371/journal.pntd.0007271] [PMID: 31150377]
[74]
Mougabure-Cueto G, Picollo MI. Insecticide resistance in vector Chagas disease: Evolution, mechanisms and management. Acta Trop 2015; 149: 70-85.
[http://dx.doi.org/10.1016/j.actatropica.2015.05.014] [PMID: 26003952]
[75]
Angheben A, Boix L, Buonfrate D, et al. Chagas disease and transfusion medicine: A perspective from non-endemic countries. Blood Transfus 2015; 13(4): 540-50.
[http://dx.doi.org/10.2450/2015.0040-15] [PMID: 26513769]
[76]
Santi AMM, Murta SMF. Antioxidant defence system as a rational target for chagas disease and leishmaniasis chemotherapy. Mem Inst Oswaldo Cruz 2022; 117: e210401.
[http://dx.doi.org/10.1590/0074-02760210401] [PMID: 35239945]
[77]
Ribeiro V, Dias N, Paiva T, et al. Current trends in the pharmacological management of Chagas disease. Int J Parasitol Drugs Drug Resist 2020; 12: 7-17.
[http://dx.doi.org/10.1016/j.ijpddr.2019.11.004] [PMID: 31862616]
[78]
Nunes MCP, Beaton A, Acquatella H, et al. American heart association rheumatic fever, endocarditis and kawasaki disease committee of the council on cardiovascular disease in the young; council on cardiovascular and stroke nursing; and stroke council.chagas cardiomyopathy: An update of current clinical knowledge and management: A scientific statement from the american heart association. Circulation 2018; 138(12): e169-209.
[http://dx.doi.org/10.1161/CIR.0000000000000599] [PMID: 30354432]
[79]
Lidani KCF, Andrade FA, Bavia L, et al. Chagas disease: From discovery to a worldwide health problem. Front Public Health 2019; 7: 166.
[http://dx.doi.org/10.3389/fpubh.2019.00166] [PMID: 31312626]
[80]
Lee BY, Bacon KM, Bottazzi ME, Hotez PJ. Global economic burden of Chagas disease: A computational simulation model. Lancet Infect Dis 2013; 13(4): 342-8.
[http://dx.doi.org/10.1016/S1473-3099(13)70002-1] [PMID: 23395248]
[81]
Alonso-Padilla J, Pinazo MJ, Gascón J. Chagas Disease: A Clinical Approach. In: Chagas disease in Europe. Switzerland: Springer Nature 2019; pp. 111-23.
[http://dx.doi.org/10.1007/978-3-030-00054-7_5]
[82]
Velasco M, Gimeno-Feliú LA, Molina I, et al. Screening for Trypanosoma cruzi infection in immigrants and refugees: Systematic review and recommendations from the spanish society of infectious diseases and clinical microbiology. Euro Surveill 2020; 25(8): 1900393.
[http://dx.doi.org/10.2807/1560-7917.ES.2020.25.8.1900393] [PMID: 32127121]
[83]
Deeks ED. Fexinidazole: First global approval. Drugs (Review) 2019; 79(2): 215-20.
[http://dx.doi.org/10.1007/s40265-019-1051-6]
[84]
Vermelho AB, Rodrigues GC, Supuran CT. Why hasn’t there been more progress in new Chagas disease drug discovery? Expert Opin Drug Discov 2020; 15(2): 145-58.
[http://dx.doi.org/10.1080/17460441.2020.1681394] [PMID: 31670987]
[85]
Kratz JM. Drug discovery for chagas disease: A viewpoint. Acta Trop 2019; 198: 105107.
[http://dx.doi.org/10.1016/j.actatropica.2019.105107] [PMID: 31351074]
[86]
Rios LE, Vázquez-Chagoyán JC, Pacheco AO, Zago MP, Garg NJ. Immunity and vaccine development efforts against Trypanosoma cruzi. Acta Trop 2019; 200: 105168.
[http://dx.doi.org/10.1016/j.actatropica.2019.105168] [PMID: 31513763]
[87]
Balouz V, Agüero F, Buscaglia CA. Chagas disease diagnostic applications: Present knowledge and future steps. Adv Parasitol 2017; 97: 1-45.
[http://dx.doi.org/10.1016/bs.apar.2016.10.001] [PMID: 28325368]
[88]
Dias JCP. Evolution of Chagas disease screening programs and control programs: Historical perspective. Glob Heart 2015; 10(3): 193-202.
[http://dx.doi.org/10.1016/j.gheart.2015.06.003] [PMID: 26407516]
[89]
Hotez PJ, Fenwick A, Molyneux DH. Collateral benefits of preventive chemotherapy expanding the war on neglected tropical diseases. N Engl J Med 2019; 380(25): 2389-91.
[http://dx.doi.org/10.1056/NEJMp1900400] [PMID: 31067365]
[90]
World Health OrganizationDracunculiasis eradication: intensifying surveillance amid continued zero human cases in Ethiopia and Mali 2021.https://www.who.int/news/item/19-03-2020-dracunculiasis-eradication-intensifying-surveillance-amid-continued-zero-human-cases-in-ethiopia-and-mali
[91]
Durrant C, Thiele EA, Holroyd N, et al. Population genomic evidence that human and animal infections in Africa come from the same populations of dracunculus medinensis. PLoS Negl Trop Dis 2020; 14(11): e0008623.
[http://dx.doi.org/10.1371/journal.pntd.0008623] [PMID: 33253172]
[92]
Hotez P, Aksoy S. PLOS neglected tropical diseases: Ten years of progress in neglected tropical disease control and elimination … more or less. PLoS Negl Trop Dis 2017; 11(4): e0005355.
[http://dx.doi.org/10.1371/journal.pntd.0005355] [PMID: 28426662]
[93]
Milton P, Hamley JID, Walker M, Basáñez MG. Moxidectin: An oral treatment for human onchocerciasis. Expert Rev Anti Infect Ther 2020; 18(11): 1067-81.
[http://dx.doi.org/10.1080/14787210.2020.1792772] [PMID: 32715787]
[94]
Mitjà O, Hays R, Ipai A, et al. Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: An open-label, non-inferiority, randomised trial. Lancet 2012; 379(9813): 342-7.
[http://dx.doi.org/10.1016/S0140-6736(11)61624-3] [PMID: 22240407]
[95]
Holmes A, Tildesley MJ, Solomon AW, et al. Modeling treatment strategies to inform yaws eradication. Emerg Infect Dis 2020; 26(11): 2685-93.
[http://dx.doi.org/10.3201/eid2611.191491] [PMID: 33079046]
[96]
Casulli A. Recognising the substantial burden of neglected pandemics cystic and alveolar echinococcosis. Lancet Glob Health 2020; 8(4): e470-1.
[http://dx.doi.org/10.1016/S2214-109X(20)30066-8] [PMID: 32199112]
[97]
Rossi P, Tamarozzi F, Galati F, et al. ERCE network.The european register of cystic echinococcosis, ERCE: State-of-the-art five years after its launch. Parasit Vectors 2020; 13(1): 236.
[http://dx.doi.org/10.1186/s13071-020-04101-6] [PMID: 32381109]
[98]
Craig PS, Hegglin D, Lightowlers MW, Torgerson PR, Wang Q. Echinococcosis. Adv Parasitol 2017; 96: 55-158.
[http://dx.doi.org/10.1016/bs.apar.2016.09.002] [PMID: 28212791]
[99]
WHOIntegrating neglected tropical diseases into global health and development: fourth WHO report on neglected tropical diseases http://www.who.int/neglected_diseases/meeting_reports/en/
[100]
Kant L. Deleting the ‘neglect’ from two neglected tropical diseases in India. Indian J Med Res 2016; 143(4): 398-400.
[http://dx.doi.org/10.4103/0971-5916.184299] [PMID: 27377493]
[101]
Hotez PJ, Alvarado M, Basáñez MG, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis 2014; 8(7): e2865.
[http://dx.doi.org/10.1371/journal.pntd.0002865] [PMID: 25058013]
[102]
Hotez PJ, Pecoul B, Rijal S, Boehme C, Aksoy S, Malecela M. Eliminating the neglected tropical diseases: Translational science and new technologies. PLoS Negl Trop Dis 201610(3): e0003895.
[http://dx.doi.org/10.1371/journal.Pntd.000389]
[103]
Lobo DA, Velayudhan R, Chatterjee P, Kohli H, Hotez PJ. The neglected tropical diseases of India and south Asia: Review of their prevalence, distribution, and control or elimination. PLoS Negl Trop Dis 2011; 5(10): e1222.
[http://dx.doi.org/10.1371/journal.pntd.0001222] [PMID: 22039553]
[104]
World Health OrganizationNeglected tropical diseases. Geneva: World Health Organization 2024.
[105]
World Health OrganizationEnding the neglect to attain the sustainable development goals—a road map for neglected tropical diseases 2021–2030. Geneva: World Health Organization 2021; p. 196.